IL73109A - Gaba-transaminase inhibiting 4-amino-(4,5-dihydro or tetrahydro-2-furan carboxylic acid and alkyl esters,process for their preparation and pharmaceutical compositions containing them - Google Patents
Gaba-transaminase inhibiting 4-amino-(4,5-dihydro or tetrahydro-2-furan carboxylic acid and alkyl esters,process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL73109A IL73109A IL73109A IL7310984A IL73109A IL 73109 A IL73109 A IL 73109A IL 73109 A IL73109 A IL 73109A IL 7310984 A IL7310984 A IL 7310984A IL 73109 A IL73109 A IL 73109A
- Authority
- IL
- Israel
- Prior art keywords
- transaminase
- gaba
- tetrahydro
- dihydro
- inhibiting
- Prior art date
Links
- 108010060511 4-Aminobutyrate Transaminase Proteins 0.000 title 1
- 102100035923 4-aminobutyrate aminotransferase, mitochondrial Human genes 0.000 title 1
- 125000005907 alkyl ester group Chemical group 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- UJJLJRQIPMGXEZ-UHFFFAOYSA-N tetrahydro-2-furoic acid Chemical compound OC(=O)C1CCCO1 UJJLJRQIPMGXEZ-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54074583A | 1983-10-11 | 1983-10-11 | |
| US54074483A | 1983-10-11 | 1983-10-11 | |
| US54074383A | 1983-10-11 | 1983-10-11 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL73109A0 IL73109A0 (en) | 1984-12-31 |
| IL73109A true IL73109A (en) | 1990-02-09 |
Family
ID=27415337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL73109A IL73109A (en) | 1983-10-11 | 1984-09-26 | Gaba-transaminase inhibiting 4-amino-(4,5-dihydro or tetrahydro-2-furan carboxylic acid and alkyl esters,process for their preparation and pharmaceutical compositions containing them |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0145875B1 (ja) |
| JP (1) | JPS60104077A (ja) |
| KR (1) | KR890001008B1 (ja) |
| AU (1) | AU569915B2 (ja) |
| CA (1) | CA1241963A (ja) |
| DE (1) | DE3485514D1 (ja) |
| DK (1) | DK483684A (ja) |
| ES (4) | ES536669A0 (ja) |
| GR (1) | GR80568B (ja) |
| HU (1) | HU201038B (ja) |
| IE (1) | IE57589B1 (ja) |
| IL (1) | IL73109A (ja) |
| NO (1) | NO168579C (ja) |
| NZ (1) | NZ209803A (ja) |
| PT (1) | PT79336B (ja) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1473757A (en) * | 1974-08-05 | 1977-05-18 | Teikoku Chem Ind Co Ltd | Ureylenethiophanes and their related compounds and production thereof |
-
1984
- 1984-09-26 IL IL73109A patent/IL73109A/xx unknown
- 1984-10-05 GR GR80568A patent/GR80568B/el unknown
- 1984-10-08 NZ NZ209803A patent/NZ209803A/en unknown
- 1984-10-08 AU AU33897/84A patent/AU569915B2/en not_active Ceased
- 1984-10-09 IE IE2584/84A patent/IE57589B1/en not_active IP Right Cessation
- 1984-10-10 KR KR1019840006265A patent/KR890001008B1/ko not_active IP Right Cessation
- 1984-10-10 EP EP84112117A patent/EP0145875B1/en not_active Expired - Lifetime
- 1984-10-10 ES ES536669A patent/ES536669A0/es active Granted
- 1984-10-10 PT PT79336A patent/PT79336B/pt not_active IP Right Cessation
- 1984-10-10 HU HU843807A patent/HU201038B/hu not_active IP Right Cessation
- 1984-10-10 DE DE8484112117T patent/DE3485514D1/de not_active Expired - Fee Related
- 1984-10-10 NO NO844066A patent/NO168579C/no unknown
- 1984-10-10 DK DK483684A patent/DK483684A/da not_active Application Discontinuation
- 1984-10-11 CA CA000465195A patent/CA1241963A/en not_active Expired
- 1984-10-11 JP JP59211614A patent/JPS60104077A/ja active Granted
-
1985
- 1985-03-27 ES ES541636A patent/ES8602746A1/es not_active Expired
- 1985-03-27 ES ES541635A patent/ES541635A0/es active Granted
- 1985-03-27 ES ES541637A patent/ES541637A0/es active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| KR890001008B1 (ko) | 1989-04-18 |
| JPS60104077A (ja) | 1985-06-08 |
| EP0145875A3 (en) | 1988-03-02 |
| PT79336B (en) | 1986-09-08 |
| ES541636A0 (es) | 1985-12-01 |
| HU201038B (en) | 1990-09-28 |
| HUT36813A (en) | 1985-10-28 |
| ES8603857A1 (es) | 1986-01-01 |
| ES8602746A1 (es) | 1985-12-01 |
| IE842584L (en) | 1985-04-11 |
| NO168579B (no) | 1991-12-02 |
| DE3485514D1 (de) | 1992-03-26 |
| EP0145875A2 (en) | 1985-06-26 |
| AU3389784A (en) | 1985-04-18 |
| EP0145875B1 (en) | 1992-02-19 |
| IL73109A0 (en) | 1984-12-31 |
| PT79336A (en) | 1984-11-01 |
| AU569915B2 (en) | 1988-02-25 |
| NZ209803A (en) | 1987-02-20 |
| IE57589B1 (en) | 1993-01-13 |
| ES8602747A1 (es) | 1985-12-01 |
| ES536669A0 (es) | 1986-01-01 |
| ES8602731A1 (es) | 1985-12-01 |
| JPH0587513B2 (ja) | 1993-12-16 |
| NO844066L (no) | 1985-04-12 |
| CA1241963A (en) | 1988-09-13 |
| KR850002969A (ko) | 1985-05-28 |
| ES541635A0 (es) | 1985-12-01 |
| ES541637A0 (es) | 1985-12-01 |
| GR80568B (en) | 1985-02-07 |
| NO168579C (no) | 1992-03-11 |
| DK483684D0 (da) | 1984-10-10 |
| DK483684A (da) | 1985-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL70881A (en) | 3-(5-aminopentyl)-amino-1-benzazepin-2-one-1-alkanoic acid derivatives,process for their preparation and pharmaceutical compositions containing them | |
| DE3366932D1 (en) | New derivatives of biliary acids, process for the production thereof and pharmaceutical compositions containing the same | |
| IL70207A (en) | Derivatives of azatricyclodecane carboxylic and azatricyclodecene carboxylic acids,process for their preparation and pharmaceutical compositions containing them | |
| IL72021A (en) | Angiotensinase inhibiting 3-(mercaptoalkyl)-2-oxo-1-pyrrolidine-acetic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| HUT37152A (en) | Process for producing ceph-3-eme-4-carboxylic acid derivatives and pharmaceutical compositions containing them | |
| PT76318B (en) | Process for preparing biodisposable iron derivatives without gastric prejudical activity and of pharmaceutical compositions containing the same | |
| HUT34211A (en) | Process for producing crostalline cepheme-carboxylic acid derivatives and pharmaceutical compositions sontaining them | |
| PT76523B (en) | Process for preparing phenoxyalkylcarboxylic acid derivatives and of pharmaceutical compositions containing the same | |
| HUT41736A (en) | Process for preparing quinoline-carboxylic acid esters and pharmaceutical compositions containing such compounds | |
| HUT48902A (en) | Process for producing new ribofuranuronic acid derivatives and pharmaceutical compositions containing them | |
| PT76809A (en) | Process for preparing 1-sulfo-2-oxoazetidine derivatives and of pharmaceutical compositions containing the same | |
| HUT48597A (en) | Process for producing pharmaceutical compositions comprising substituted 2-phenyl-4-quinolinecarboxylic acid derivatives and the new quinolinecarboxylic acid derivatives | |
| ZA792043B (en) | Esters of substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines,process for the preparation thereof and pharmaceutical compositions containing them | |
| PT76870A (en) | Process for the preparation of 1,4-dihydropiridine derivatives and pharmaceutical compositions containing them | |
| HU895952D0 (en) | Process for the preparation of substituted pyrrolidone-2-carboxylic acid derivatives and pharmaceutical compositions containing them | |
| PT78939B (en) | Process for preparing esters of pantetheine and pantethine with 3-pyridineacetic or 3-(3-pyridylmethoxycarbonyl)-propionic acid and of pharmaceutical compositions containing the same | |
| HUT50324A (en) | Process for producing thiophene-2-carboxylic acid derivatives and pharmaceutical compositions comprising such compounds | |
| DE3166538D1 (en) | Novel quinoline derivatives, pharmaceutical compositions containing such compounds, and method for the preparation of these compounds | |
| IL67041A (en) | 2-aminocyclopentane alkanoic and alkenoic acid esters,process for their preparation and pharmaceutical compositions containing them | |
| DE3380875D1 (en) | Piperidine-3-carboxylic acid derivatives, process for their preparation, and pharmaceutical compositions containing them | |
| HU891560D0 (en) | Process for the preparation of pharmaceutical compositions containing quinoline derivatives | |
| PT73400A (en) | Amide derivatives of p-isobutyl-phenyl-propionic acid process for their preparation and related pharmaceutical compositions | |
| IL65396A0 (en) | Esters of mercapto acyl-carnitines,process for their preparation and pharmaceutical compositions containing same | |
| IL73109A (en) | Gaba-transaminase inhibiting 4-amino-(4,5-dihydro or tetrahydro-2-furan carboxylic acid and alkyl esters,process for their preparation and pharmaceutical compositions containing them | |
| HUT48272A (en) | Process for producing nukleinic acid derivatives and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HC | Change of name of proprietor(s) |
Owner name: AVENTIS INC. Free format text: FORMER NAME:MERRELL PHARMACEUTICALS INC. |